The Discounted Cash Flow (DCF) valuation of Oxford BioMedica PLC (OXB.L) is (2,600.86) GBP. With the latest stock price at 430.00 GBP, the upside of Oxford BioMedica PLC based on DCF is -704.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.4% - 13.5% | 10.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (6,661.88) - (1,678.75) | (2,600.86) |
| Upside | -1649.3% - -490.4% | -704.9% |